1-3 of 3
Tadeusz Robak, Prof.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Sustained Benefit of Zanubrutinib vs Ibrutinib in Patients With R/R CLL/SLL: Final Comparative Analysis of ALPINE

Clinical Trials & Observations
Jennifer R. Brown, Barbara Eichhorst, Nicole Lamanna, Susan M O'Brien, M.D., Constantine S. Tam, Lugui Qiu, Wojciech Jurczak, Keshu Zhou, Martin Šimkovič, Jiří Mayer, Amanda Gillespie-Twardy, Alessandra Ferrajoli, Peter Stephen Ganly, Robert Weinkove, Sebastian Grosicki, Andrzej Mital, Tadeusz Robak, Prof., Anders Osterborg, Habte A. Yimer, Megan (Der Yu) Wang, Tommi Salmi, Liping Wang, Jessica Li, Kenneth Wu, Aileen Cleary Cohen, Mazyar Shadman
Journal: Blood
Blood blood.2024024667.
https://doi.org/10.1182/blood.2024024667
Published: 2024
Includes: Supplemental data
Journal Articles

Expression of Smad Proteins as a Potential Prognostic Factor in Chronic Lymphocytic Leukemia

Magdalena Witkowska, MD, Barbara Cebula-Obrzut, PhD, Agata Majchrzak, PhD, Aleksandra Medra, PhD, Tadeusz Robak, Prof, Piotr Smolewski, Prof
Journal: Blood
Blood (2014) 124 (21): 1957.
https://doi.org/10.1182/blood.V124.21.1957.1957
Published: 2014
Journal Articles

Nanoparticles – a Novel Approach to Chronic Lymphocytic Leukemia Treatment?

Ida Franiak-Pietryga, PhD, Ewelina Ziolkowska, MSc, Barbara Ziemba, PhD, Dietmar Appelhans, PhD, Brigitte Voit, Prof., Joanna Gora-Tybor, Prof., Tadeusz Robak, Prof., Barbara Klajnert, Prof., Maria Bryszewska, Prof.
Journal: Blood
Blood (2012) 120 (21): 4601.
https://doi.org/10.1182/blood.V120.21.4601.4601
Published: 2012